Peliosis hepatis epidemiology and demographics

Jump to navigation Jump to search

Peliosis hepatis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peliosis hepatis from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Peliosis hepatis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peliosis hepatis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peliosis hepatis epidemiology and demographics

CDC on Peliosis hepatis epidemiology and demographics

Peliosis hepatis epidemiology and demographics in the news

Blogs on Peliosis hepatis epidemiology and demographics

Directions to Hospitals Treating Peliosis hepatis

Risk calculators and risk factors for Peliosis hepatis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Epidemiology and Demographics

The epidemiology of Peliosis hepatis is not completely understood, Peliosis Hepatis is usually asymptomatic, thus most cases go undiagnonised. [1]

Multiple studies associate Peliosis Hepatis with pulmonary tuberculosis, carcinomatosis, HIV infection, aplastic anemia treated with anabolic steroids, systemic lupus erythematosus treated with high-dose glucocorticoids, and patients who underwent renal transplantation. [2].

  • The prevalence was 0.2 percent in patients with pulmonary tuberculosis
  • Five cases of PH were observed in a study of 17,000 patients with HIV infection
  • The prevalence ranged from 0 to 22 percent in patients who underwent renal transplantation. [3]

References

Template:WS Template:WH